Publications

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

 83
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Tags:

Previous Article

Oncogene mutation in colorectal cancer leads to metabolic reprogramming

Next Article

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Related Posts

Hydrogen sulfide-mediated persulfidation regulates homocysteine metabolism and enhances ferroptosis in non-small cell lung cancer

Hydrogen sulfide-mediated persulfidation regulates homo...

 65

Hyperglycemia-triggered lipid peroxidation destabilizes STAT4 and impairs anti-viral Th1 responses in type 2 diabetes

Hyperglycemia-triggered lipid peroxidation destabilizes...

 65

Macrophages protect against sensory axon loss in peripheral neuropathy

Macrophages protect against sensory axon loss in periph...

 100